Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Alemania
EUR 18,00
Cantidad disponible: 2 disponibles
Añadir al carritoix, 362p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Current Cancer Research. Sprache: Englisch.
Librería: ThriftBooks-Atlanta, AUSTELL, GA, Estados Unidos de America
EUR 126,96
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 125,39
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Basi6 International, Irving, TX, Estados Unidos de America
EUR 127,76
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Librería: Phatpocket Limited, Waltham Abbey, HERTS, Reino Unido
EUR 119,37
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 131,62
Cantidad disponible: 1 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 141,19
Cantidad disponible: 1 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 131,56
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Speedyhen LLC, Hialeah, FL, Estados Unidos de America
EUR 150,76
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: NEW.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 150,14
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Humana Press 2018-08-13, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Librería: Chiron Media, Wallingford, Reino Unido
EUR 137,97
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 144,39
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. In.
Librería: Speedyhen, Hertfordshire, Reino Unido
EUR 116,78
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: NEW.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 149,25
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 152,01
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 159,37
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. 2018. Hardcover. . . . . .
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 164,21
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 171,63
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Brand New. 2nd edition. 636 pages. 9.25x6.10x1.46 inches. In Stock.
Idioma: Inglés
Publicado por Springer International Publishing AG, CH, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 191,38
Cantidad disponible: 1 disponibles
Añadir al carritoHardback. Condición: New. Second Edition 2018.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 192,68
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Softcover reprint of the original 2nd ed. 2018 edition NO-PA16APR2015-KAP.
Idioma: Inglés
Publicado por Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Librería: moluna, Greven, Alemania
EUR 150,48
Cantidad disponible: 1 disponibles
Añadir al carritoGebunden. Condición: New. Summarize the unique pathobiology of head and neck cancersAddresses signaling pathways and individual proteins that are important in causing or supporting the aggressive nature of head and neck cancerDiscusses the sequencing and epigen.
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 202,09
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. 2018. Hardcover. . . . . . Books ship from the US and Ireland.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 199,31
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. 2018. Paperback. . . . . .
Idioma: Inglés
Publicado por Springer Nature Switzerland, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Librería: preigu, Osnabrück, Alemania
EUR 140,00
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Molecular Determinants of Head and Neck Cancer | Barbara Burtness (u. a.) | Taschenbuch | vi | Englisch | 2018 | Springer Nature Switzerland | EAN 9783030087791 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 216,51
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Librería: moluna, Greven, Alemania
EUR 166,97
Cantidad disponible: Más de 20 disponibles
Añadir al carritoKartoniert / Broschiert. Condición: New.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 239,39
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 362.
Librería: Buchpark, Trebbin, Alemania
EUR 130,32
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: Hervorragend. Zustand: Hervorragend | Seiten: 636 | Sprache: Englisch | Produktart: Bücher | Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.